Avenue Therapeutics, Inc. filed its 10-K on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, , gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.515 USD | -27.18% | -53.73% | -62.61% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-62.61% | 3.66M | |
-2.63% | 103B | |
+1.62% | 95.28B | |
+1.46% | 22.15B | |
-16.67% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.21% | 16.05B | |
+5.41% | 13.68B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- ATXI Stock
- News Avenue Therapeutics, Inc.
- Avenue Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt